NSN NSN Parts NSN 6505016564667

NSN 6505-01-656-4667, 6505016564667 Fentanyl Transdermal System Parts Sourcing

If you have been looking for Sandoz Inc, Actavis Pharma Inc, Mylan Pharmaceuticals Inc, Par Pharmaceutical Inc, Janssen Pharmaceuticals Inc parts listed alongside the NSN 6505016564667, ASAP Distribution has you covered with our unmatched inventory of items Fentanyl Transdermal System. With over 2 billion parts readily available for purchase on our website, customers can get competitive pricing offers and rapid lead-times on top NSN part numbers such as NDC00781-7243-55, NDC00591-3213-72, NDC00378-9123-98, NDC49884-0763-78, NDC50458-0093-05. Explore our NSN parts catalog at your leisure, or you may take advantage of our provided search engine to find specific parts in a matter of moments. If you are interested in this particular component or others listed across our website, you may begin the procurement process at any time through the submission of an Instant RFQ form. Using the information that you submit to us, our team of industry experts will quickly craft you a quote that accommodates your individual needs and requirements for NSN 6505016564667.

Alternative NSN: 6505-01-656-4667 Item Name : Fentanyl Transdermal System NIIN: 016564667 NCB Code: USA (01)

Part Number's List for NSN 6505-01-656-4667, 6505016564667

Part No Manufacturer Item Name QTY RFQ
NDC00781-7243-55 Sandoz Inc fentanyl transdermal system Avl RFQ
NDC00591-3213-72 Actavis Pharma Inc fentanyl transdermal system Avl RFQ
NDC00378-9123-98 Mylan Pharmaceuticals Inc fentanyl transdermal system Avl RFQ
NDC49884-0763-78 Par Pharmaceutical Inc fentanyl transdermal system Avl RFQ
NDC50458-0093-05 Janssen Pharmaceuticals Inc fentanyl transdermal system Avl RFQ
NDC00406-9075-76 Mallinckrodt Inc fentanyl transdermal system Avl RFQ

Characteristics Data of NSN 6505016564667

MRCCriteriaCharacteristic
FEATSpecial FeaturesROUTE: TRANSDERMAL; DOSE FORM: PATCH, TRANSDERMAL 72 HOURS; STRENGTH: 75 MCG/HOUR; DEA CONTROLLED II SUBSTANCE; INDIVIDUALLY SEALED; CONTAINS FIVE (75 MCG/HR) TRANSDERMAL SYSTEMS; STORE IN ORIGINAL UNOPENED POUCH. STORE UP TO 20 C TO 25 C (68 F TO 77 F; STRICT ADHERENCE TO THE RECOMMENDED HANDLING AND DISPOSAL INSTRUCTIONS ON PRODUCT INSERT IS OF THE UTMOST IMPORTANCE TO PREVENT ACCIDENTAL EXPOSURE; EXPOSURE OF FENTANYL TRANSDERMAL SYSTEM APPLICATION SITE AND SURROUNDING AREA TO DIRECT EXTERNAL HEAT SOURCES, SUCH AS HEATING PADS, SAUNAS, HOT TUBS AND HEATED WATER BEDS MAY INCREASE FENTANYL ABSORPTION AND RESULT IN FATAL OVERDOSE OF FENTANYL AND DEATH; PATIENTS WHO DEVELOP FEVER OR INCREASED CORE BODY TEMPERATURE DUE TO STRENOUS EXERTION ARE ALSO AT RISK FOR INCREASED FENTANYL EXPOSURE AND MAY REQUIRE AN ADJUSTMENT IN THE DOSE OF FENTANYL TRANSDERMAL SYSTEM TO AVOID OVERDOSE
CSLZUsual Dose75 MCG/HR
CBBLFeatures ProvidedINDIVIDUALLY SEALED
CRYCControlled Substance ClassificationSCHEDULE II
CXCYPart Name Assigned By Controlling AgencyDURAGESIC-75 (FENTANYL TRANSDERMAL SYSTEM) 75MCG/HR, 5S
MRCDecoded RequirementClear Text Reply
INSTANT RFQ